| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 2 | Adipocytokine signaling pathway 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 3 | Adrenergic signaling in cardiomyocytes 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4 | African trypanosomiasis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 5 | AGE-RAGE signaling pathway in diabetic complications 2 genes, 2 drugs (DrugBank), 35 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 6 | Aldosterone synthesis and secretion 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 7 | Allograft rejection 2 genes, 3 drugs (DrugBank), 24 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 8 | Alzheimer disease 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 9 | Amoebiasis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 10 | AMPK signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 11 | Amyotrophic lateral sclerosis (ALS) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 12 | Antifolate resistance 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 13 | Antigen processing and presentation 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 14 | Apelin signaling pathway 2 genes, 2 drugs (DrugBank), 45 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 15 | Apoptosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 16 | Asthma 3 genes, 4 drugs (DrugBank), 27 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 17 | Autoimmune thyroid disease 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 18 | Autophagy - animal 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 19 | Autophagy - other 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 20 | Breast cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 21 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 22 | Calcium signaling pathway 6 genes, 3 drugs (DrugBank), 19 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [4] CHRM1, CHRM2, CHRM3, CHRM5 |
D01000 |
Bethanechol |
[1] 98 |
| [1] CYSLTR1 |
D00529 |
Montelukast |
[5] 13, 46, 85, 98, 228 |
| D08229 |
| 23 | cAMP signaling pathway 2 genes, 1 drug (DrugBank), 1 disease shown |
[2] CHRM1, CHRM2 |
D01000 |
Bethanechol |
[1] 98 |
| 24 | Cellular senescence 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 25 | Central carbon metabolism in cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 26 | cGMP-PKG signaling pathway 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 27 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 28 | Choline metabolism in cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 29 | Cholinergic synapse 5 genes, 1 drug (DrugBank), 1 disease shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
[1] 98 |
| 30 | Collecting duct acid secretion 2 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
[1] 98 |
| D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 31 | Colorectal cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 32 | Cortisol synthesis and secretion 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 33 | Cushing syndrome 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 34 | Cytokine-cytokine receptor interaction 3 genes, 4 drugs (DrugBank), 24 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 35 | Dilated cardiomyopathy (DCM) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 36 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 37 | Endocrine resistance 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 38 | Epstein-Barr virus infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 39 | ErbB signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 40 | Fc epsilon RI signaling pathway 3 genes, 4 drugs (DrugBank), 27 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 41 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 42 | GABAergic synapse 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 43 | Gastric acid secretion 3 genes, 5 drugs (DrugBank), 20 diseases shown |
[2] ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
[1] 98 |
| D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [1] CHRM3 |
D01000 |
Bethanechol |
[1] 98 |
| 44 | Gastric cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 45 | Glioma 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 46 | Graft-versus-host disease 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 47 | Growth hormone synthesis, secretion and action 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 48 | Hematopoietic cell lineage 3 genes, 4 drugs (DrugBank), 24 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 49 | Hepatitis B 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 50 | Hepatitis C 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 51 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 52 | Herpes simplex virus 1 infection 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 53 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 54 | Human cytomegalovirus infection 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 55 | Human immunodeficiency virus 1 infection 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 56 | Human papillomavirus infection 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 57 | Human T-cell leukemia virus 1 infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 58 | Hypertrophic cardiomyopathy (HCM) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 59 | IL-17 signaling pathway 2 genes, 3 drugs (DrugBank), 24 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 60 | Inflammatory bowel disease (IBD) 3 genes, 4 drugs (DrugBank), 24 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 61 | Influenza A 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 62 | Insulin resistance 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 63 | Insulin secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D01000 |
Bethanechol |
[1] 98 |
| 64 | Insulin signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 65 | Intestinal immune network for IgA production 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 66 | JAK-STAT signaling pathway 3 genes, 4 drugs (DrugBank), 39 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 67 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 68 | Legionellosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 69 | Leishmaniasis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 70 | Longevity regulating pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 71 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 72 | Malaria 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 73 | MAPK signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 74 | Metabolic pathways 2 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
[1] 98 |
| D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 75 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 76 | Morphine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 77 | mTOR signaling pathway 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 78 | Natural killer cell mediated cytotoxicity 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 79 | Necroptosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 80 | Neuroactive ligand-receptor interaction 24 genes, 9 drugs (DrugBank), 29 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
[1] 98 |
| [1] CYSLTR1 |
D00529 |
Montelukast |
[5] 13, 46, 85, 98, 228 |
| D08229 |
| [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| [1] NR3C1 |
D00689 |
Beclomethasone dipropionate |
[2] 97, 98 |
| D07495 |
| D00246 |
Budesonide |
[10] 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
| D07981 |
Fluticasone |
[4] 98, 228, 299, 306 |
| D01708 |
Fluticasone propionate |
[4] 98, 228, 299, 306 |
| D00690 |
Mometasone furoate |
[1] 98 |
| 81 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 82 | Nicotine addiction 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 83 | NOD-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 84 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 85 | Osteoclast differentiation 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 86 | Oxidative phosphorylation 2 genes, 4 drugs (DrugBank), 20 diseases shown |
[2] ATP4A, ATP4B |
D08903 |
Dexlansoprazole |
[1] 98 |
| D01984 |
Esomeprazole |
[6] 6, 46, 86, 98, 298, 299 |
| D04056 |
| D07917 |
| D09339 |
| D00355 |
Lansoprazole |
[6] 63, 71, 98, 166, 222, 299 |
| D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 87 | Pancreatic cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 88 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D01000 |
Bethanechol |
[1] 98 |
| 89 | Pathogenic Escherichia coli infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 90 | Pathways in cancer 4 genes, 5 drugs (DrugBank), 48 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 91 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 92 | Pertussis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 93 | Phospholipase D signaling pathway 3 genes, 3 drugs (DrugBank), 48 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| [1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 94 | PI3K-Akt signaling pathway 4 genes, 3 drugs (DrugBank), 36 diseases shown |
[2] CHRM1, CHRM2 |
D01000 |
Bethanechol |
[1] 98 |
| [1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 95 | Prostate cancer 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 96 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 97 | Regulation of actin cytoskeleton 5 genes, 1 drug (DrugBank), 1 disease shown |
[5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 |
D01000 |
Bethanechol |
[1] 98 |
| 98 | Renin secretion 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 99 | Renin-angiotensin system 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 100 | Retrograde endocannabinoid signaling 16 genes, 1 drug (DrugBank), 8 diseases shown |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 101 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 102 | RIG-I-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 103 | Salivary secretion 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] CHRM3 |
D01000 |
Bethanechol |
[1] 98 |
| 104 | Serotonergic synapse 3 genes, 1 drug (DrugBank), 8 diseases shown |
[3] GABRB1, GABRB2, GABRB3 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 105 | Shigellosis 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 106 | Sphingolipid signaling pathway 2 genes, 2 drugs (DrugBank), 26 diseases shown |
[1] FCER1A |
D05251 |
Omalizumab |
[6] 53, 65, 98, 162, 226, 299 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 107 | Systemic lupus erythematosus 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 108 | T cell receptor signaling pathway 2 genes, 3 drugs (DrugBank), 24 diseases shown |
[1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 109 | Taste transduction 7 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] CHRM3 |
D01000 |
Bethanechol |
[1] 98 |
| [6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00549 |
Propofol |
[8] 6, 21, 22, 34, 46, 84, 98, 296 |
| 110 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 111 | Th1 and Th2 cell differentiation 2 genes, 3 drugs (DrugBank), 4 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] IL5 |
D04923 |
Mepolizumab |
[4] 44, 45, 98, 162 |
| D08985 |
Reslizumab |
[3] 44, 45, 98 |
| 112 | Th17 cell differentiation 2 genes, 2 drugs (DrugBank), 36 diseases shown |
[1] IL4R |
D10354 |
Dupilumab |
[1] 98 |
| [1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 113 | Thermogenesis 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 114 | Thyroid hormone signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 115 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 116 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 117 | Toxoplasmosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 118 | Tuberculosis 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 119 | Type I diabetes mellitus 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 120 | Type II diabetes mellitus 2 genes, 2 drugs (DrugBank), 52 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 121 | Vascular smooth muscle contraction 1 gene, 1 drug (DrugBank), 18 diseases shown |
[1] AGTR1 |
D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 122 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| 123 | Yersinia infection 1 gene, 1 drug (DrugBank), 23 diseases shown |
[1] TNF |
D02598 |
Infliximab |
[23] 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |